Summary by Futu AI
Intelligent Bio Solutions Inc. has filed a Form S-3 with the Securities and Exchange Commission (SEC) on March 4, 2024, to register shares for potential future sale. This registration statement pertains to the resale of up to 636,367 shares of common stock, which may be issued upon the exercise of certain Series G Warrants and Placement Agent Warrants. The Series G Warrants were issued to certain selling stockholders in exchange for their exercise of existing Series E Warrants, and the Placement Agent Warrants were issued to Ladenburg Thalmann & Co. Inc., the placement agent for the issuance of the Inducement Warrants. The company will not receive any proceeds from the sale of shares by the selling stockholders but will receive the exercise price if...Show More